212 related articles for article (PubMed ID: 38678014)
1. A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy.
Ascheid D; Baumann M; Pinnecker J; Friedrich M; Szi-Marton D; Medved C; Bundalo M; Ortmann V; Öztürk A; Nandigama R; Hemmen K; Ergün S; Zernecke A; Hirth M; Heinze KG; Henke E
Nat Commun; 2024 Apr; 15(1):3599. PubMed ID: 38678014
[TBL] [Abstract][Full Text] [Related]
2. Assessing Advantages and Drawbacks of Rapidly Generated Ultra-Large 3D Breast Cancer Spheroids: Studies with Chemotherapeutics and Nanoparticles.
Holub AR; Huo A; Patel K; Thakore V; Chhibber P; Erogbogbo F
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575896
[TBL] [Abstract][Full Text] [Related]
3. 3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing.
Ahn J; Kim DH; Koo DJ; Lim J; Park TE; Lee J; Ko J; Kim S; Kim M; Kang KS; Min DH; Kim SY; Kim Y; Jeon NL
Acta Biomater; 2023 Jul; 165():153-167. PubMed ID: 36243378
[TBL] [Abstract][Full Text] [Related]
4. 3D Bioprinted Vascularized Tumour for Drug Testing.
Han S; Kim S; Chen Z; Shin HK; Lee SY; Moon HE; Paek SH; Park S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340319
[TBL] [Abstract][Full Text] [Related]
5. Vascularized Lung Cancer Model for Evaluating the Promoted Transport of Anticancer Drugs and Immune Cells in an Engineered Tumor Microenvironment.
Kim D; Hwang KS; Seo EU; Seo S; Lee BC; Choi N; Choi J; Kim HN
Adv Healthc Mater; 2022 Jun; 11(12):e2102581. PubMed ID: 35286780
[TBL] [Abstract][Full Text] [Related]
6. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
7. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
8. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
[TBL] [Abstract][Full Text] [Related]
9. A 3D Heterotypic Multicellular Tumor Spheroid Assay Platform to Discriminate Drug Effects on Stroma versus Cancer Cells.
Weydert Z; Lal-Nag M; Mathews-Greiner L; Thiel C; Cordes H; Küpfer L; Guye P; Kelm JM; Ferrer M
SLAS Discov; 2020 Mar; 25(3):265-276. PubMed ID: 31658853
[TBL] [Abstract][Full Text] [Related]
10. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.
Wenzel C; Riefke B; Gründemann S; Krebs A; Christian S; Prinz F; Osterland M; Golfier S; Räse S; Ansari N; Esner M; Bickle M; Pampaloni F; Mattheyer C; Stelzer EH; Parczyk K; Prechtl S; Steigemann P
Exp Cell Res; 2014 Apr; 323(1):131-143. PubMed ID: 24480576
[TBL] [Abstract][Full Text] [Related]
11. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
12. Characterization of multicellular breast tumor spheroids using image data-driven biophysical mathematical modeling.
Bowers HJ; Fannin EE; Thomas A; Weis JA
Sci Rep; 2020 Jul; 10(1):11583. PubMed ID: 32665565
[TBL] [Abstract][Full Text] [Related]
13. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
14. Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.
Mukundan S; Bell J; Teryek M; Hernandez C; Love AC; Parekkadan B; Chan LL
J Fluoresc; 2022 Mar; 32(2):521-531. PubMed ID: 34989923
[TBL] [Abstract][Full Text] [Related]
15. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
16. Modeling selective elimination of quiescent cancer cells from bone marrow.
Cavnar SP; Rickelmann AD; Meguiar KF; Xiao A; Dosch J; Leung BM; Cai Lesher-Perez S; Chitta S; Luker KE; Takayama S; Luker GD
Neoplasia; 2015 Aug; 17(8):625-33. PubMed ID: 26408255
[TBL] [Abstract][Full Text] [Related]
17. Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy.
Lan M; Lu W; Zou T; Li L; Liu F; Cai T; Cai Y
Cell Mol Life Sci; 2021 Mar; 78(5):2105-2129. PubMed ID: 33386887
[TBL] [Abstract][Full Text] [Related]
18. Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release.
Sabhachandani P; Sarkar S; Mckenney S; Ravi D; Evens AM; Konry T
J Control Release; 2019 Feb; 295():21-30. PubMed ID: 30550941
[TBL] [Abstract][Full Text] [Related]
19. Multi-Inlet Spheroid Generator for High-Throughput Combinatorial Drug Screening Based on the Tumor Microenvironment.
Han S; Kim S; Hong HK; Cho YB; Moon HE; Paek SH; Park S
ACS Appl Mater Interfaces; 2023 Jul; 15(27):32087-32098. PubMed ID: 37234040
[TBL] [Abstract][Full Text] [Related]
20. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
